PedAM
Pediatric Disease Annotations & Medicines
| Disease | vascular disease |
| Phenotype | |kidney disease |
| Sentences | 118 |
| PubMedID- 23898220 | The effective use of vitamin b supplements has been described for prevention of cardiovascular disease in patients with kidney disease.10 likewise, it has been reported that patients taking vitamin b supplements, in particular folate, have significant improvement in their signs and symptoms of diabetic peripheral neuropathy.11–17 a commercially available vitamin b compound reported to reduce anesthesia, paresthesia, causalgia, and other symptoms of homocysteine associated with vascular damage is metanx® (pamlab, covington, la, usa). |
| PubMedID- 24441913 | Aim: vascular calcification, an independent risk factor for cardiovascular disease in patients with chronic kidney disease(ckd), refers to the mineralization of vascular smooth muscle cells(vsmcs) caused by phenotypic changes toward osteoblast-like cells. |
| PubMedID- 24650765 | Increased numbers of the population predict the risk of cardiovascular disease in patients with chronic kidney disease [40], patients receiving hemodialysis [41], and patients selected for coronary angiography [42]. |
| PubMedID- 22629024 | Risk factors of cardiovascular disease among children with chronic kidney disease in gaza strip. |
| PubMedID- 25530222 | The use of vitamin d receptor activators (vdras) is an independent predictor of a lower risk of death from cardiovascular disease (cvd) in patients with chronic kidney disease (ckd). |
| PubMedID- 21436791 | Background: disorders in mineral metabolism are associated with risk for cardiovascular disease (cvd) events in patients with kidney disease as well as in the general population. |
| PubMedID- 24157604 | Exciting new discoveries have highlighted fgf-23 as an independent risk factor for cardiovascular disease in patients with chronic kidney disease. |
| PubMedID- 20881938 | Epigenetic alterations are associated with inflammation and cardiovascular disease in patients with chronic kidney disease. |
| PubMedID- 23113674 | Aim: the current data have proven the pivotal role of inflammation in the development of atherosclerosis and cardiovascular diseases in patients with chronic kidney disease (ckd). |
| PubMedID- 21629196 | The increased risk of cardiovascular disease (cvd) in patients with chronic kidney disease (ckd) has been well documented. |
| PubMedID- 21562144 | Background: markers of collagen turnover have not been well studied in the context of cardiovascular disease in patients with chronic kidney disease (ckd). |
| PubMedID- 21448530 | [assessment and management of cardiovascular disease in patients with chronic kidney disease]. |
| PubMedID- 25874106 | Therefore, hyperphosphataemia is a widely recognized risk factor for mortality and cardiovascular disease in patients with chronic kidney disease (ckd) [1]. |
| PubMedID- 23146975 | Assessment of peripheral vascular disease in patients with chronic kidney disease. |
| PubMedID- 25499229 | Vitamin d receptor polymorphism in chronic kidney disease patients with complicated cardiovascular disease. |
| PubMedID- 21647319 | Vitamin d deficiency appears to be an underestimated risk factor for cardiovascular disease in patients with chronic kidney disease. |
| PubMedID- 21595847 | Vascular calcification is the most important cause of cardiovascular disease in patients with chronic kidney disease (ckd). |
| PubMedID- 25550968 | Asymmetric dimethylarginine (adma) has been involved in the development mechanism of cardiovascular disease (cvd) in patients with chronic kidney disease. |
| PubMedID- 22470397 | Proteinuria is an important risk factor not only for progression of renal failure but also for the development of cardiovascular disease in patients with chronic kidney disease (ckd) [17]. |
| PubMedID- 20347511 | Background: vascular calcification contributes to cardiovascular disease in patients with chronic kidney disease (ckd). |
| PubMedID- 21784369 | Assessment and management of vascular disease risk in patients with chronic kidney disease. |
| PubMedID- 22127399 | A plethora of evidence has indicated that strict bp reduction is indispensable to improve patients’ prognosis, inadequate control of bp is thus leaving patients at risk of cardiovascular disease, particularly in patients with chronic kidney disease (ckd) and uncontrollable hypertension [1]. |
| PubMedID- 26264647 | Type 4 cardiorenal syndrome (crs) is a life-threatening world health problem in which chronic kidney disease leads to progressive cardiovascular disease. |
| PubMedID- 24055267 | Background and aims: p-cresyl sulfate (pcs) and indoxyl sulfate (is) were not only novel but essential factors associated with cardiovascular disease and mortality in patients with chronic kidney disease and hemodialysis. |
| PubMedID- 26133318 | Association between ophthalmological changes and cardiovascular diseases in patients with chronic kidney disease undergoing hemodialysis. |
| PubMedID- 23745333 | Some studies showed correlation between the elevated fgf-23 level and increased mortality from cardiovascular disease in patients with chronic kidney disease. |
| PubMedID- 23704321 | A severe form of arthropathy is the most common clinical presentation of aku but patients often suffer from cardiovascular disease (frequent cause of death) and kidney disease as well. |
| PubMedID- 24129557 | Lipoprotein(a) is one of the strongest genetically determined risk factors for cardiovascular disease, and patients with chronic kidney disease have major disturbances in lipoprotein(a) metabolism. |
| PubMedID- 24912660 | Conclusions: in patients with chronic kidney disease, intestinal uptake of p-cresol associates with cardiovascular disease independent of renal function. |
| PubMedID- 21523678 | Diabetes, hypertension (hypertrophy and left ventricular failure), impaired fibrinolysis and coagulation processes, as well as the rapid development of atherosclerosis (partly associated with chronic inflammation) are responsible for higher prevalence of cardiovascular diseases in patients with chronic kidney disease. |
| PubMedID- 23345995 | Patients with chronic kidney disease (ckd) associated with cardiovascular disease (cvd) have a higher risk of death than the general population [1]. |
| PubMedID- 23046408 | Updating the lipids hypothesis of inflammation and vascular disease in patients with chronic kidney disease: a stearoyl-coa desaturase affair. |
| PubMedID- 23338722 | Chronic kidney disease (ckd) is associated with accelerated cardiovascular disease (cvd) risk and a higher cvd event rate. |
| PubMedID- 24795256 | These bone-derived humoral factors might place the bone at the centre of cardiovascular disease associated with chronic kidney disease. |
| PubMedID- 25924679 | Background: reliable estimates of the impacts of chronic kidney disease (ckd) stage, with and without cardiovascular disease, on hospital costs are needed to inform health policy. |
| PubMedID- 24231387 | The age-rage pathway and its relation to cardiovascular disease in patients with chronic kidney disease. |
| PubMedID- 24924917 | Cardiovascular disease is often associated with chronic kidney disease and vice versa; myocardial vitamin d receptors (vdrs) are among the probable links between the 2 disorders. |
| PubMedID- 21111939 | Background: endothelial dysfunction (ed) is closely linked to cardiovascular disease and outcome in patients with chronic kidney disease (ckd). |
| PubMedID- 26409637 | Retinopathy and the risk of cardiovascular disease in patients with chronic kidney disease (from the chronic renal insufficiency cohort study). |
| PubMedID- 24084210 | Reduced nitric oxide bioavailability contributes to increased cardiovascular disease risk in patients with chronic kidney disease (ckd). |
| PubMedID- 23557545 | Background: dyslipidemia, a well-known risk factor for cardiovascular disease, is common in patients with kidney disease. |
| PubMedID- 21835038 | Multivariable analyses were used to adjust for the possible confounders age, sex, race, smoking, primary kidney disease, presence of cardiovascular disease (cvd; angina pectoris, coronary disease, and/or myocardial infarction), and presence of diabetes mellitus (dm). |
| PubMedID- 21251296 | Schematic depiction of the pathological process of tubular degeneration and tubulointerstitial fibrosis characteristic of tubulointerstitial diseases, and also of later stages of glomerular and renovascular diseases leading to chronic kidney disease (adapted from references [87]and [291]). |
| PubMedID- 21406649 | Serum levels of phosphorus, parathyroid hormone, and calcium and risks of death and cardiovascular disease in individuals with chronic kidney disease: a systematic review and meta-analysis. |
| PubMedID- 24012024 | Aki was associated with chronic kidney disease, history of peripheral vascular disease, blood transfusion, and higher euroscore (p <0.05 for all). |
| PubMedID- 26354563 | The objective of this study is to determine the prevalence of peripheral vascular disease (pvd) in patients with chronic kidney disease (ckd). |
| PubMedID- 24489988 | Systemic inflammation and oxidative stress are nontraditional risk factors that are associated with premature cardiovascular disease commonly observed in patients with chronic kidney disease (ckd) [1, 2]. |
| PubMedID- 22916063 | Given the large burden of cardiovascular disease in individuals with chronic kidney disease, assessing the relationship between estimated grr (egfr) and vascular stiffness parameters in its early stage is important. |
| PubMedID- 20884698 | Chronic kidney disease and risk of major cardiovascular disease and non-vascular mortality: prospective population based cohort study. |
| PubMedID- 24876668 | A severe form of arthropathy is the most common clinical presentation of aku but patients often suffer also from cardiovascular disease (frequent cause of death) and kidney disease and though organs may be affected. |